ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Análisis del registro unicéntrico del programa Código Infarto: cohorte retrospectiva / Analysis of the unicentric registry of the Infarction Code program: retrospective cohort

Otoniel Toledo-Salinas, Saira Sanjuana Gómez-Flores, Ernesto García-Hernández, Verónica Armenta-Pérez, Andrés García-Rincón

Resumen


 

Resumen

Introducción: el síndrome coronario agudo (SICA) es la manifestación más grave de la enfermedad coronaria. El programa Código Infarto (CI) tiene como objetivo mejorar la atención de estos pacientes.

Objetivo: describir la presentación clínica y los resultados del programa CI de una unidad de cuidados coronarios (UCC).

Material y métodos: se analizó una base de datos de una UCC con 5 años de registros consecutivos. Se incluyeron pacientes con diagnóstico de SICA. Se compararon los grupos con infarto agudo de miocardio con y sin elevación del segmento ST mediante las pruebas t de Student, U de Mann-Whitney y chi cuadrada. Se calculó el riesgo relativo (RR) y el intervalo de confianza del 95% (IC 95%) de los factores de riesgo cardiovascular para mortalidad.

Resultados: se analizaron 4678 sujetos, 78.7% hombres, con media de edad de 63 años (± 10.7). El 80.76% presentó infarto agudo de miocardio con desnivel positivo del segmento ST y se otorgó fibrinolítico en el 60.8% de los casos. Se realizó intervencionismo coronario percutáneo en el 81.4% de los pacientes, el cual fue exitoso en el 82.5% de los eventos. Los pacientes catalogados como CI presentaron mortalidad del 6.8% frente a 11.7%, p = 0.001. La ventilación mecánica invasiva tuvo una RR de 26.58 (IC 95%: 20.61-34.3) y el choque circulatorio una RR de 20.86 (IC 95%: 16.16-26.93).

Conclusiones: el programa CI disminuyó 4.9% la mortalidad. La fibrinólisis temprana y la angiografía coronaria exitosa son factores protectores para mortalidad dentro de la UCC.

 

Abstract

Background: Acute coronary syndrome (ACS) is the most serious manifestation of coronary heart disease. The Infarction Code (according to its initialism in Spanish, CI: Código Infarto) program aims to improve the care of these patients.

Objective: To describe the clinical presentation and outcomes of CI program in a coronary care unit (CCU).

Material and methods: A database of a CCU with 5 years of consecutive records was analyzed. Patients diagnosed with ACS were included. The groups with acute myocardial infarction with and without ST-segment elevation were compared using Student's t, Mann-Whitney U and chi-squared tests. We calculated the relative risk (RR) and 95% confidence intervals (95% CI) of cardiovascular risk factors for mortality.

Results: A total of 4678 subjects were analyzed, 78.7% men, mean age 63 years (± 10.7). 80.76% presented acute myocardial infarction with positive ST-segment elevation and fibrinolytic was granted in 60.8% of cases. Percutaneous coronary intervention was performed in 81.4% of patients, which was successful in 82.5% of events. Patients classified as CI presented mortality of 6.8% vs. 11.7%, p = 0.001. Invasive mechanical ventilation had an RR of 26.58 (95% CI: 20.61-34.3) and circulatory shock an RR of 20.86 (95% CI: 16.16-26.93).

Conclusions: The CI program decreased mortality by 4.9%. Early fibrinolysis and successful coronary angiography are protective factors for mortality within CCU.


Palabras clave


Síndrome Coronario Agudo; Isquemia Miocárdica; Infarto de Miocardio de la Pared Anterior; Angina Inestable; Enfermedades Cardiovasculares / Acute Coronary Syndrome; Myocardial Ischemia; Anterior Wall Myocardial Infarction; Unstable Angina; Cardiovascul

Texto completo:

PDF PUBMED DOI

Referencias


Jensen RV, Hjortbak MV, Bøtker HE. Ischemic Heart Disease: An Update. Semin Nucl Med. 2020;50(3):195-207. doi: 10.1053/j.semnuclmed.2020.02.007

Severino P, D'Amato A, Pucci M, et al. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int J Mol Sci. 2020;21(21):8118. doi: 10.3390/ijms21218118

Thygesen K, Alpert JS, Jaffe AS, et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction. Circulation. 2018;13;138(20):e618-51. doi: 10.1161/CIR.0000000000000617

Ibanez B, James S, Agewall S, et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. doi: 10.1093/eurheartj/ehx393

Duggan JP, Peters AS, Trachiotis GD, et al. Epidemiology of Coronary Artery Disease. Surg Clin North Am. 2022;102(3):499-516. doi: 10.1016/j.suc.2022.01.007

Por el Grupo Cooperativo RENASICA. El Registro Nacional de los Síndromes Isquémicos Coronarios Agudos (RENASICA). Sociedad Mexicana de Cardiología. Arch Cardiol Mex 2002;72:S45-64.

Martinez-Sanchez C, Borrayo G, Carrillo J, et al.; RENASICA III Investigators. Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The Third National Registry of Acute Coronary Syndromes (RENASICA III). Arch Cardiol Mex. 2016;86(3):221-32. doi: 10.1016/j.acmx.2015.04.001

Borrayo-Sánchez G, Madrid-Miller A, Arriaga-Nava R, et al. Riesgo estratificado de los síndromes coronarios agudos. Resultados del primer Renasca-IMSS. Rev Med Inst Mex Seguro Soc. 2010;48(3):259-64.

Borrayo-Sánchez G, Rosas-Peralta M, Ramírez-Arias E, et al. Stemi and NSTEMI: Real-world study in Mexico (RENASCA). Arch Med Res. 2018;49(8):609-19. doi: 10.1016/j.arcmed.2019.01.005

Borrayo-Sánchez G, Pérez-Rodríguez G, Martínez-Montañez OG, et al. Protocolo para atención de infarto agudo de miocardio en urgencias: Código infarto. Rev Med Inst Mex Seguro Soc. 2017;55(2):233-46.

Borrayo-Sánchez G, Rosas-Peralta M, Pérez-Rodríguez G, et al. Infarto agudo del miocardio con elevación del segmento ST: Código I. Rev Med Inst Mex Seguro Soc. 2018;56(1):26-37.

García-Castillo A, Jerjes-Sánchez C, Martínez Bermúdez P, et al. Registro Mexicano de Síndromes Coronarios Agudos. Arch Cardiol Méx. 2005; 75(Suppl 1): 6-19.

Collet JP, Thiele H, Barbato E, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-367. doi: 10.1093/eurheartj/ehaa575

Borrayo-Sánchez G, Alcocer-Gamba MA, Araiza-Garaygordobil D, et al. Interinstitutional clinical practice guidelines for the treatment of acute myocardial infarction. Gac Med Mex. 2020;156(6):559-69. doi: 10.24875/GMM.M21000455

Ramonfaur D, Hinojosa-González DE, Paredes-Vázquez JG. Killip-Kimball classification in octogenarians with acute coronary syndrome: An 11-year experience. Arch Cardiol Mex. 2022;92(4):425-30. doi: 10.24875/ACM.21000046

Femia G, French JK, Juergens C, et al. Right ventricular myocardial infarction: pathophysiology, clinical implications and management. Rev Cardiovasc Med. 2021;22(4):1229-40. doi: 10.31083/j.rcm2204131

Kataoka Y, Doi T. Coronary artery ectasia: Importance of its risk stratification and management. Int J Cardiol. 2021;322:43-4. doi: 10.1016/j.ijcard.2020.08.061

Arriaga-Dávila J, Pérez-Rodríguez G, Borrayo-Sánchez G. Dimensiones de calidad enfocadas en el protocolo de atención Código Infarto. Rev Med Inst Mex Seguro Soc. 2017;55(3):382-7.

Powers WJ, Rabinstein AA, Ackerson T, et al Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-418. doi: 10.1161/STR.0000000000000158

Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021

Bosco E, Hsueh L, McConeghy KW, et al. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: A systematic review. BMC Medical Research Methodology. 2021;21(1). doi: 10.1186/s12874-021-01440-5

Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. doi: 10.1001/jama.2016.0287

Robledo-Aburto ZA, Duque-Molina C, Lara-Saldaña GJ, et al. Protocolo de atención Código Infarto, hacia la federalización de IMSS Bienestar. Rev Med Inst Mex Seguro Soc. 2022;60(Suppl 2):49-53.

Zeymer U, Ludman P, Danchin N, et al; ACS STEMI investigators. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. Eur Heart J. 2021;42(44):4536-49. doi: 10.1093/eurheartj/ehab342

Sinclair JE, Plante M, Harrison MF, et al. ST-elevation myocardial infarction after thrombolytic therapy with Tenecteplase for acute ischaemic stroke. BMJ Case Rep. 2023;16(6):e252253. doi: 10.1136/bcr-2022-252253

Thielmann M, Wendt D, Slottosch I, et al. Coronary Artery Bypass Graft Surgery in Patients With Acute Coronary Syndromes After Primary Percutaneous Coronary Intervention: A Current Report From the North-Rhine Westphalia Surgical Myocardial Infarction Registry. J Am Heart Assoc. 2021;10(18):e021182. doi: 10.1161/JAHA.121.021182

Vallabhajosyula S, Kashani K, Dunlay SM, et al. Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000-2014. Ann Intensive Care. 2019;9(1):96. doi: 10.1186/s13613-019-0571-2

Jentzer JC, Bhat AG, Patlolla SH, et al. Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes. Crit Care Explor. 2022;4(2):e0637.30.

Wang WH, Hong YC, Chen HM, et al. Risk Factors and Outcome of Acute Kidney Injury following Acute Myocardial Infarction-A Case Series Study from 2009 to 2019. J Clin Med. 2022;11(20):6083. doi: 10.3390/jcm11206083.


Enlaces refback

  • No hay ningún enlace refback.